
Mizuho Senior Biotech Analyst Salim Syed highlights key companies in the news he covers heading into the new year
BiotechTV - News
00:00
Vaxcyte phase 3 adult data timeline
Salim details Vaxcyte's VAX-31 adult non-inferiority trial and expects phase 3 data in Q4.
Play episode from 21:13
Transcript


